Friday, December 16, 2011

What is the prognosis for T3, N2, M0 Borrmann poorly differentiated gastric carcinoma in a 40-year-old female?

Surgery has been done with clear margins, but with spread to two lymph nodes. The patient is undergoing chemotherapy now with epirubicin and oxaliplatin (infusion) and oral Xeloda (two tablets twice a day for 14 days during each cycle). How long will she live?

No comments:

Post a Comment